| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.08. | Ceribell earns Medicare win for brain monitoring tech | ||
| 31.07. | Fresenius Medical Care launches real-world evidence initiative | ||
| 31.07. | Siemens Healthineers lowers sales outlook, ups EPS guide for 2026 on Q3 results | ||
| 31.07. | enVVeno Medical wins FDA IDE for non-surgical transcatheter replacement venous valve | ||
| 31.07. | Boston Scientific restructuring cuts reportedly set to hit Ireland, Costa Rica | ||
| 31.07. | SoundHealth announces additional fundraising | ||
| 30.07. | Stryker posts Q2 beats, narrows guidance after progress on cyberattack recovery | ||
| 30.07. | Dexcom Q2 results beat expectations, lead to increased sales outlook | ||
| 30.07. | MiMedx to acquire Sanara MedTech for $350M | ||
| 30.07. | Siemens Healthineers promotes new president, head of Americas from within | ||
| 30.07. | Total Flow Medical earns FDA nod for femoral arterial cannula for cardiopulmonary bypass | ||
| 30.07. | Baxter posts Q2 results that 'exceeded expectations,' raises guidance | ||
| 30.07. | MMI gets FDA green light to expand study of surgical robot in Alzheimer's | ||
| 30.07. | CereVasc opens new Massachusetts manufacturing, research facility | ||
| 30.07. | CroíValve change at the top signals intent to bring coaptation valve to US | ||
| 29.07. | Smith+Nephew gets FDA nod for TESSA spatial surgery platform | ||
| 29.07. | Medtronic leads $37M Series C for AFib ablation mapping tech developer CoreMap | ||
| 29.07. | VDyne enrolls first patient in IDE study of tricuspid valve | ||
| 29.07. | GE HealthCare records Q2 beats on 6% sales growth | ||
| 29.07. | Boston Scientific cuts 2026 guidance again despite Q2 beats | ||
| 28.07. | Abbott initiates real-world study of TriClip in leaky heart valves | ||
| 28.07. | Aurenar closes $5.7M seed round for noninvasive neuromod | ||
| 28.07. | Johnson & Johnson to pay $5.5B to resolve talc litigation | ||
| 28.07. | CroíValve picks longtime Edwards leader as new CEO | ||
| 28.07. | Xeltis raises $23.3M to bring vascular access device to US |